(Adds: Revance Therapeutics ( RVNC ), Enterprise Bancorp ( EBTC ), Novolex,

Arthur J Gallagher ( AJG ), Dow Updates: Omnicom Group ( OMC ))

Dec 9 (Reuters) - The following bids, mergers,

acquisitions and disposals were reported by 1430 GMT on Monday:

** Anti-wrinkle injection maker Revance Therapeutics ( RVNC )

has agreed to be bought for $3.10 per share by

privately held Crown Laboratories, instead of the $6.66 per

share agreed previously, the two companies said.

** Enterprise Bancorp ( EBTC ) and Independent Bank

, the parent of Rockland Trust, have agreed to merge in

a cash-and-stock deal valued at $562 million, they said, as

regional lenders continue to consolidate their operations.

** Apollo Global Management ( APO )-owned Novolex will

buy packaging products maker Pactiv Evergreen ( PTVE ) in a $6.7

billion deal, the companies said.

** Arthur J Gallagher ( AJG ) said it would acquire

insurance broker AssuredPartners in an all-cash deal worth

$13.45 billion, as it looks to bolster its focus on property and

casualty and employee benefits across the U.S.

** Omnicom Group ( OMC ) has struck a $13.25 billion

all-stock deal to buy rival Interpublic Group, creating

the world's largest advertising agency as traditional players

look to better compete with Big Tech firms amid accelerating use

of AI.

** Dow said it would sell a 40% stake in some

U.S. Gulf Coast infrastructure assets to a fund managed by

Macquarie Asset Management for $2.4 billion as it looks to focus

more on its core chemicals business.

** Nature Infrastructure Capital and Davidson Kempner

Capital Management said that they had jointly acquired the

Dutch-based solar power and storage project development platform

of Greencells Group.

(Compiled by Rajarshi Roy and Kamal Choudhury in Bengaluru)